haematology
Blood cancers

Ibrutinib-associated invasive fungal disease seen in patients with CLL


The risk of invasive fungal disease in CLL patients treated with ibrutinib may be higher than previously thought, a new study suggests. Unusual presentations of IFD were seen in 35 patients with CLL and non-Hodgkin lymphoma, Israeli clinicians report in...

The risk of invasive fungal disease in CLL patients treated with ibrutinib may be higher than previously thought, a new...

Read more